Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Dellinger, M. Levy, A. Rhodes, D. Annane, H. Gerlach, S. Opal, J. Sevransky, C. Sprung, I. Douglas, R. Jaeschke, T. Osborn, M. Nunnally, S. Townsend, K. Reinhart, R. Kleinpell, D. Angus, C. Deutschman, F. Machado, G. Rubenfeld, S. Webb, R. Beale, J. Vincent, R. Moreno, The Subgroup (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012Intensive Care Medicine, 39
F. Jacobs (2011)
Relation between mean arterial pressure and renal function in the early phase of shock: a prospective, explorative cohort studyCritical Care, 15
V. Ranieri, B. Thompson, P. Barie, J. Dhainaut, I. Douglas, S. Finfer, B. Gårdlund, J. Marshall, A. Rhodes, A. Artigas, D. Payen, J. Tenhunen, Hussein Al-Khalidi, Vivian Thompson, J. Janes, W. Macias, B. Vangerow, M. Williams (2012)
Drotrecogin alfa (activated) in adults with septic shock.The New England journal of medicine, 366 22
Medicine Downloaded from nejm.org by NORMAN PARADIS on March 18, 2014. For personal use only. No other uses without permission. Copyright © 2014 Massachusetts Medical Society
D. Annane, P. Vignon, A. Renault, P. Bollaert, C. Charpentier, Claude Martin, G. Troché, J. Ricard, G. Nitenberg, L. Papazian, É. Azoulay, É. Bellissant (2007)
Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trialThe Lancet, 370
A. Bourgoin, M. Leone, A. Delmas, F. Garnier, J. Albanèse, Claude Martin (2005)
Increasing mean arterial pressure in patients with septic shock: Effects on oxygen variables and renal function*Critical Care Medicine, 33
A. Walkey, R. Wiener, J. Ghobrial, L. Curtis, E. Benjamin (2011)
Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis.JAMA, 306 20
(2001)
N Engl J Med
C. Sprung, D. Annane, D. Keh, R. Moreno, M. Singer, K. Freivogel, Y. Weiss, J. Benbenishty, A. Kalenka, H. Forst, P. Laterre, K. Reinhart, B. Cuthbertson, D. Payen, J. Briegel (2008)
Hydrocortisone therapy for patients with septic shock.The New England journal of medicine, 358 2
Manuel, Ivers, Ryant, Guyen, Uzanne, Avstad, Ulie, Essler, Lexandria, Uzzin, Ernhard, Noblich, Dward, Eterson, Ichael, Omlanovich (2001)
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockThe New England Journal of Medicine, 345
(2004)
Crit Care Med
A. Perner, N. Haase, A. Guttormsen, J. Tenhunen, G. Klemenzson, A. Åneman, K. Madsen, M. Møller, Jeanie Elkjær, Lone Poulsen, A. Bendtsen, R. Winding, M. Steensen, P. Berezowicz, P. Søe-Jensen, M. Bestle, K. Strand, J. Wiis, J. White, K. Thornberg, Lars Quist, Jonas Nielsen, L. Andersen, L. Holst, K. Thormar, A. Kjældgaard, M. Fabritius, F. Mondrup, F. Pott, T. Møller, P. Winkel, J. Wetterslev (2012)
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.The New England journal of medicine, 367 2
J. Russell, K. Walley, J. Singer, A. Gordon, Paul Hébert, D. Cooper, C. Holmes, S. Mehta, J. Granton, Michelle Storms, D. Cook, J. Presneill, D. Ayers (2008)
Vasopressin versus norepinephrine infusion in patients with septic shock.The New England journal of medicine, 358 9
T. Pottecher, S. Calvat, H. Dupont, J. Durand-gasselin, P. Gerbeaux (2006)
Haemodynamic management of severe sepsis: recommendations of the French Intensive Care Societies (SFAR/SRLF) Consensus Conference, 13 October 2005, Paris, FranceCritical Care, 10
D. Backer, P. Biston, J. Devriendt, C. Madl, D. Chochrad, C. Aldecoa, A. Brasseur, P. Defrance, P. Gottignies, J. Vincent (2010)
Comparison of dopamine and norepinephrine in the treatment of shock.The New England journal of medicine, 362 9
Angel López, J. Lorente, J. Steingrub, J. Bakker, A. Mcluckie, S. Willatts, M. Brockway, A. Anzueto, L. Holzapfel, D. Breen, M. Silverman, J. Takala, J. Donaldson, C. Arneson, Geraldine Grove, S. Grossman, R. Grover (2004)
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*Critical Care Medicine, 32
S. Strandgaard, J. Olesen, E. Skinhøj, N. Lassen (1973)
Autoregulation of Brain Circulation in Severe Arterial HypertensionBritish Medical Journal, 1
M. Dünser, J. Takala, H. Ulmer, V. Mayr, G. Luckner, S. Jochberger, F. Daudel, P. Lepper, W. Hasibeder, S. Jakob (2009)
Arterial blood pressure during early sepsis and outcomeIntensive Care Medicine, 35
R. Bone, R. Balk, F. Cerra, R. Dellinger, A. Fein, W. Knaus, R. Schein, W. Sibbald (1992)
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.Chest, 101 6
M. Poukkanen, E. Wilkman, S. Vaara, V. Pettilä, K. Kaukonen, A. Korhonen, A. Uusaro, S. Hovilehto, O. Inkinen, R. Laru-Sompa, R. Hautamäki, A. Kuitunen, S. Karlsson (2013)
Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI studyCritical Care, 17
D. Heyland, J. Muscedere, J. Drover, Xuran Jiang, A. Day (2011)
Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trialsCritical Care, 15
David LeDoux, M. Astiz, C. Carpati, E. Rackow (2000)
Effects of perfusion pressure on tissue perfusion in septic shockCritical Care Medicine, 28
BackgroundThe Surviving Sepsis Campaign recommends targeting a mean arterial pressure of at least 65 mm Hg during initial resuscitation of patients with septic shock. However, whether this blood-pressure target is more or less effective than a higher target is unknown.MethodsIn a multicenter, open-label trial, we randomly assigned 776 patients with septic shock to undergo resuscitation with a mean arterial pressure target of either 80 to 85 mm Hg (high-target group) or 65 to 70 mm Hg (low-target group). The primary end point was mortality at day 28.ResultsAt 28 days, there was no significant between-group difference in mortality, with deaths reported in 142 of 388 patients in the high-target group (36.6%) and 132 of 388 patients in the low-target group (34.0%) (hazard ratio in the high-target group, 1.07; 95% confidence interval [CI], 0.84 to 1.38; P=0.57). There was also no significant difference in mortality at 90 days, with 170 deaths (43.8%) and 164 deaths (42.3%), respectively (hazard ratio, 1.04; 95% CI, 0.83 to 1.30; P=0.74). The occurrence of serious adverse events did not differ significantly between the two groups (74 events [19.1%] and 69 events [17.8%], respectively; P=0.64). However, the incidence of newly diagnosed atrial fibrillation was higher in the high-target group than in the low-target group. Among patients with chronic hypertension, those in the high-target group required less renal-replacement therapy than did those in the low-target group, but such therapy was not associated with a difference in mortality.ConclusionsTargeting a mean arterial pressure of 80 to 85 mm Hg, as compared with 65 to 70 mm Hg, in patients with septic shock undergoing resuscitation did not result in significant differences in mortality at either 28 or 90 days. (Funded by the French Ministry of Health; SEPSISPAM ClinicalTrials.gov number, NCT01149278.)
The New England Journal of Medicine – The New England Journal of Medicine
Published: Apr 24, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.